Comparing Cialis to Other ED Medications

🗣️ Patient Experience
ATC Code And Dosage Forms
Guidelines for Proper Use of Cialis
What is Cialis used for?

Andrew Riegel, FA0609000788279 (NAF, October 18, 2006) (finding the addition of the generic term "buy" to Complainant's CIALIS mark did not overcome the confusing similarity between the disputed domain name and the CIALIS mark); Lilly ICOS LLC v. Jay Kim, D2004-0891 (WIPO, January 28, 2005) (finding the addition of the generic word "generic" and the generic letter "a" to Complainant's CIALIS mark did not prevent the domain name from being confusingly similar to the CIALIS mark); and Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (determining that the addition of the words "drug", "online", "buying" and "guide" to Complainant's registered CIALIS trademark did not eliminate the confusing similarity between the CIALIS mark and the domain name because the additional words did not distinguish the owner of the disputed name from Complainant).� In the present case, Respondents have merely added generic and/or descriptive words and phrases to the CIALIS mark in the Domain Names.� Respondents� addition of these words and phrases to the Domain Names does not negate the distinctiveness of Complainant's CIALIS mark. Additionally, when a domain name incorporates a distinctive mark in its entirety that creates sufficient similarity between a mark and a domain name to render the domain name confusingly similar.� EAuto v. Triple S. Auto Parts, D2000-0047 (WIPO, March 24, 2000).� In the case at hand, the Domain Names are confusingly similar to the CIALIS mark because they incorporate the mark in its entirety.� See Lilly ICOS LLC v.

Cialis is a popular choice for erectile dysfunction treatment.
It increases blood flow by relaxing penile muscles.
Pharmacists can advise on proper dose and timing.
Cialis is available with a doctor's prescription only.
Side effects may include nasal congestion.
Never share your medication with others.
Check for drug interactions with your other medicines.
Cialis may cause vision changes in some cases.
It is important to disclose your health conditions.
Avoid taking Cialis if you have low blood pressure.
Some pharmacies offer discreet packaging.
Health insurance may cover some Cialis costs.

Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (finding that the disputed domain name was confusingly similar to the CIALIS trademark because it incorporated the distinctive CIALIS mark in its entirety) (Annex 3, N).� With the exception of the generic and/or descriptive words and phrases, the Domain Names consist of Complainant's CIALIS mark in its entirety.� Thus, the Domain Names are confusingly similar to Complainant's CIALIS trademark. ]�� The Respondents have no rights or legitimate interests in respect of the Domain Names. �� (1)�� Respondents are not using the Domain Names for a legitimate business purpose. Respondents have no rights or legitimate interests in the Domain Names.� There is no evidence that the Respondents have been commonly known by the term "CIALIS" or any of the corresponding Domain Names.� All of the active websites associated with the Domain Names resolve to the same networks which promote and allegedly sell �Generic� CIALIS brand product, which have not been approved by the U.S. Food and Drug Administration ("FDA") or any other health authority and are unlawful pharmaceutical products.� To date, there is no "generic" version of CIALIS brand product approved by the FDA or any other health authority.� As a result, any "generic" CIALIS product is an unlawful, counterfeit pharmaceutical product.�� By using the mark CIALIS in the Domain Names, the Respondents are luring consumers in search of Complainant's CIALIS brand product to websites that promote "generic" and brand name pharmaceutical products, including products which are arguably competitive with Complainant's CIALIS product.� Such use does not demonstrate a legitimate right or interest in the Domain Names. See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (finding that using the disputed domain names to redirect to websites advertising and promoting competing products is not consistent with a bona fide offering of goods and services under Policy �4(c)(i) or a legitimate noncommercial or fair use according to Policy �4(c)(iii)) (Annex 3, P) and Lilly ICOS LLC v. Alexey Stoun, D2006-1170 (WIPO, November 16, 2006) (finding that the registrant did not have any legitimate right or interest in the disputed domain because registrant was using the mark CIALIS in the domain at issue to direct consumers in search of CIALIS brand product to a website which advertised "generic" CIALIS product as well as competitive products).� While approximately 10 of the websites associated with the Domain Names are not currently active, it is apparent from the Respondents� use of the �active� Domain Names that all of the Domain Names have been registered and are being used cialis soft tabs 20mg in bad faith.� Prior panels have held that even passive holding of a domain name can constitute bad faith use and registration.� In Telstra Corporation Limited v. Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000), WIPO recognized that a respondent's inaction (e.g.

Traveling with prescription medication requires planning, especially for international travel.
Keep Cialis in its original pharmacy-labeled container to avoid issues with security or customs.
Carry a copy of your prescription or a letter from your doctor, particularly when traveling abroad.
Check the legal status of tadalafil in your destination country, as laws can vary.
Do not pack your medication in checked luggage; always keep it in your carry-on bag.
Temperature extremes in cargo holds can degrade the medication's effectiveness.
Plan for time zone changes if you are on a daily dosing schedule; adjust timing gradually.
Ensure you have an adequate supply for the entire trip plus a few extra days in case of delays.
Know how to contact a doctor or find a pharmacy at your destination if needed.
Travel insurance that covers medical care and prescription refills can provide peace of mind.

passive holding) could represent bad faith use of a domain name under certain circumstances.� The decision noted that the determination as to what circumstances constituted "certain circumstances" worthy of a bad faith determination would be fact specific to each case.� In Telstra, some of the particular circumstances leading to a finding of bad faith included: (1) complainant's mark had a strong reputation and was widely known; (2) respondent failed to show any evidence of actual or contemplated good faith use by it of the domain name; and (3) it was impossible to conceive of any plausible actual or contemplated active use of the domain name by respondent that would not be illegitimate, such as being a passing off, an infringement of consumer protection legislation, or trademark infringement.� Such factors are present in the case at hand.� As set forth in detail above, Complainant's CIALIS mark has a strong reputation and is widely known throughout the world.� In addition, Respondents have no apparent rights or legitimate interest in the Domain Names.� As described above, Respondents are using Complainant's CIALIS trademark in other domain names to attract Internet consumers to its websites, which are online pharmacies advertising and selling counterfeit versions of Complainant�s CIALIS brand product in violation of Complainant�s intellectual property rights and various national laws concerning the sale of pharmaceuticals.� With respect to the few �inactive� Domain Names, there is no plausible use of the associated websites by Respondents that would not be illegitimate.� Respondents� registration of multiple domain names which incorporate Complainant's distinctive CIALIS mark further demonstrates Respondents� improper conduct.� In light of these factors, Respondents' "passive holding" of some of the Domain Names amounts to use in bad faith. Moreover, as previous Panels have held, "rights or legitimate interests cannot be created where the user of the domain name at issue would not choose such a name unless he was seeking to create an impression of association with the complainant." See Eli Lilly and Company v. media/broadcasting, Lee Shung, D2010-1079 (WIPO, September 14, 2010) (determining that the respondent did not have any right or legitimate interest in the domain <36cialis.com> where the respondent sold unauthorized or counterfeit products of the complainant).� Respondents clearly chose the Domain Names in order to create an impression of association with Complainant and Complainant's well-known CIALIS mark.� In light of these factors, it is apparent from the websites associated with the Domain Names that the Respondents are attempting to capitalize on the valuable reputation and goodwill of the CIALIS mark to direct Internet users to its websites.�� (2)� Respondents are not authorized by Complainant to use the CIALIS trademark.

🗣️ Patient Experience

User Reviews

Auto Parts, D2000-0047 (WIPO, March 24, 2000).� In the case at hand, the Domain Names are confusingly similar to the CIALIS mark because they incorporate the mark in its entirety.� See Lilly ICOS LLC v. Dan Eccles, D2004-0750 (WIPO, November 8, 2004) (finding that the disputed domain name was confusingly similar to the CIALIS trademark because it incorporated the distinctive CIALIS mark in its entirety) (Annex 3, N).� With the exception of the generic and/or descriptive words and phrases, the Domain Names consist of Complainant's CIALIS mark in its entirety.� Thus, the Domain Names are confusingly similar to Complainant's CIALIS trademark. ]�� The Respondents have no rights or legitimate interests in respect of the Domain Names. �� (1)�� Respondents are not using the Domain Names for a legitimate business purpose. Respondents have no rights or legitimate interests in the Domain Names.� There is no evidence that the Respondents have been commonly known by the term "CIALIS" or any of the corresponding Domain Names.� All of the active websites associated with the Domain Names resolve to the same networks which promote and allegedly sell �Generic� CIALIS brand product, which have not been approved by the U.S. Complainant has not given Respondents permission, authorization, consent or license to use its CIALIS mark.� Despite this fact, however, the Domain Names resolve to websites enabling the Respondents to benefit from the strength of Complainant's CIALIS mark and the reputation and goodwill of the product with which the mark is associated. [c.]�� The Domain Names were registered and are being used in bad faith. Complainant has a June 17, 1999 constructive use date of the CIALIS trademark based upon its U.S.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	20mg	270 + 10 Pills	335.21€ 319.25€
Cialis Professional	40mg	120 + 4 Pills	436.68€ 415.89€
Cialis Generic	10mg	360 + 10 Pills	388.49€ 369.99€
Cialis Generic	5mg	20 Pills	41.99€ 39.99€
Cialis Generic	2.5mg	20 Pills	40.73€ 38.79€
Cialis Generic	40mg	20 Pills	59.47€ 56.64€
Cialis Generic	60mg	120 + 8 Pills	240.18€ 228.74€
Cialis Original	20mg	34 + 2 Pills	183.99€ 175.23€
Cialis Generic	5mg	60 + 4 Pills	86.02€ 81.92€
Cialis Soft Tabs	20mg	20 + 2 Pills	66.98€ 63.79€
Cialis Professional	20mg	180 + 4 Pills	423.11€ 402.96€
Cialis Professional	20mg	270 + 6 Pills	623.07€ 593.40€
Cialis Generic	10mg	270 + 10 Pills	308.71€ 294.01€
Cialis Black	80mg	20 Pills	71.83€ 68.41€

trademark rights.� Media coverage of the CIALIS brand product is dated as early as 2001.� Complainant has extensively marketed and advertised its pharmaceutical product using the CIALIS trademark.� Therefore, because it is reasonable to infer that the CIALIS trademark is well-known, it is highly likely that the Respondents knew of Complainant's CIALIS mark at the time of registering over 70 confusingly similar Domain Names. According to Policy �4(b)(ii), evidence of bad faith registration and use is shown when a respondent has registered a domain name in order to prevent the trademark owner from reflecting the mark in a corresponding domain name, provided the respondent has engaged in a pattern of such conduct.�� See Eli Lilly and Company v.

ATC Code And Dosage Forms

Food and Drug Administration ("FDA") or any other health authority and are unlawful pharmaceutical products.� To date, there is no "generic" version of CIALIS brand product approved by the FDA or any other health authority.� As a result, any "generic" CIALIS product is an unlawful, counterfeit pharmaceutical product.�� By using the mark CIALIS in the Domain Names, the Respondents are luring consumers in search of Complainant's CIALIS brand product to websites that promote "generic" and brand name pharmaceutical products, including products which are arguably competitive with Complainant's CIALIS product.� Such use does not demonstrate a legitimate right or interest in the Domain Names. See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (finding that using the disputed domain names to redirect to websites advertising and promoting competing products is not consistent with a bona fide offering of goods and services under Policy �4(c)(i) or a legitimate noncommercial or fair use according to Policy �4(c)(iii)) (Annex 3, P) and Lilly ICOS LLC v. Alexey Stoun, D2006-1170 (WIPO, November 16, 2006) (finding that the registrant did not have any legitimate right or interest in the disputed domain because registrant was using the mark CIALIS in the domain at issue to direct consumers in search of CIALIS brand product to a website which advertised "generic" CIALIS product as well as competitive products).� While approximately 10 of the websites associated with the Domain Names are not currently active, it is apparent from the Respondents� use of the �active� Domain Names that all of the Domain Names have been registered and are being used cialis soft tabs 20mg in bad faith.� Prior panels have held that even passive holding of a domain name can constitute bad faith use and registration.� In Telstra Corporation Limited v. Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000), WIPO recognized that a respondent's inaction (e.g.

Payment Methods

Guidelines for Proper Use of Cialis

Special Precautions

Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (Annex 3, P) and Eli Lilly and Company v. Grace Beaumont et.

Cialis can help men regain sexual function.
It is a long-acting ED medication.
Side effects are usually mild and temporary.
Serious reactions require immediate medical attention.
Discuss all health conditions with your doctor.
Follow dosing guidelines strictly.
Cialis is available in various formulations.
Check if your pharmacy offers consultations.
Use Cialis as part of a comprehensive treatment plan.
Avoid using Cialis with certain heart medications.
Inform your healthcare provider of all supplements used.
Use caution if you experience vision or hearing changes.

al, FA1504001615093 (NAF, June 5, 2015).� In this case, the Respondents have registered over 70 domains which incorporate the Complainant's CIALIS mark. Moreover, in order to establish a pattern of conduct, one need not demonstrate an impact against multiple trademark owners.� Instead, while a pattern of conduct typically involves multiple domain names directed against multiple complainants, it may involve multiple domain names directed against a single complainant.� See Telstra Corporation Limited v.

Drug Class	Interaction Effect	Advice
Nitrates	Severe hypotension	Avoid use altogether
Alpha-blockers	Increased blood pressure effects	Consult doctor for dosage adjustments
CYP3A4 inhibitors	Increased Cialis levels, risk of side effects	Dose adjustment necessary

Ozurls, D2001-0046 (WIPO, March 20, 2001) (finding that fifteen domain names that involved Telstra's mark and a series of services, products, geographical descriptors, or generic words obviously involves a pattern of conduct directed against Telstra, stopping it from reflecting its mark in corresponding domain names).� Such is the case here, where the Respondents registered over 70 Domain Names, all of which incorporate the Complainant's well-known and distinctive CIALIS mark.� Further, promoting competing products under another�s mark disrupts a trademark owner�s business and reveals bad faith registration and use according to Policy �4(b)(iii).

What is Cialis used for?

Complainant has a June 17, 1999 constructive use date of the CIALIS trademark based upon its U.S. trademark rights.� Media coverage of the CIALIS brand product is dated as early as 2001.� Complainant has extensively marketed and advertised its pharmaceutical product using the CIALIS trademark.� Therefore, because it is reasonable to infer that the CIALIS trademark is well-known, it is highly likely that the Respondents knew of Complainant's CIALIS mark at the time of registering over 70 confusingly similar Domain Names. According to Policy �4(b)(ii), evidence of bad faith registration and use is shown when a respondent has registered a domain name in order to prevent the trademark owner from reflecting the mark in a corresponding domain name, provided the respondent has engaged in a pattern of such conduct.�� See Eli Lilly and Company v. Darren K. Headley et al., D2103-1303 (WIPO, September 4, 2013) (registering 10 domain names incorporating the CIALIS mark demonstrated that the respondent registered and was using the disputed domain names in bad faith per paragraph 4(b)(ii)).� Moreover, prior Forum Panels found that the registration of multiple domains incorporating the Complainant�s CIALIS mark revealed bad faith registration and use pursuant to Policy �4(b)(ii).� See Eli Lilly and Company v.

Market Demand Trends

Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (Annex 3, P) and Eli Lilly and Company v. Grace Beaumont et. al, FA1504001615093 (NAF, June 5, 2015).� In this case, the Respondents have registered over 70 domains which incorporate the Complainant's CIALIS mark. Moreover, in order to establish a pattern of conduct, one need not demonstrate an impact against multiple trademark owners.� Instead, while a pattern of conduct typically involves multiple domain names directed against multiple complainants, it may involve multiple domain names directed against a single complainant.� See Telstra Corporation Limited v. Ozurls, D2001-0046 (WIPO, March 20, 2001) (finding that fifteen domain names that involved Telstra's mark and a series of services, products, geographical descriptors, or generic words obviously involves a pattern of conduct directed against Telstra, stopping it from reflecting its mark in corresponding domain names).� Such is the case here, where the Respondents registered over 70 Domain Names, all of which incorporate the Complainant's well-known and distinctive CIALIS mark.� Further, promoting competing products under another�s mark disrupts a trademark owner�s business and reveals bad faith registration and use according to Policy �4(b)(iii).